Lamivudine + Tenofovir Disoproxil

Fixed-dose combination

This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.

Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.

Active ingredients

Lamivudine lamivudine
Tenofovir Disoproxil tenofovir-disoproxil

Brands with this exact combination

Brand	Composition & strength	Manufacturer
Lamivudine 300mg / Tenofovir disoproxil 245mg tabletsES GB	300 mg / 245 mg	Cipla EU Ltd
CIMDUOUS	tablet Lamivudine 300 mg + Tenofovir Disoproxil 300 mg	Viatris Specialty LLC
Lamivudine and Tenofovir Disoproxil FumarateUS	300 mg	Viatris Specialty LLC
LAMIVUDINA/TENOFOVIR DISOPROXILO CIPLAES	tablet Lamivudine 300 mg + Tenofovir Disoproxil 245 mg	Cipla Europe
lamivudina + tenofovirES	300 mg / 245 mg	Cipla Europe

Same combination in other markets

No product with this combination is recorded in the other covered markets yet.

Only the main ingredient is the same — this is NOT the same fixed-dose combination. View the main ingredient

See warnings for these ingredients

Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.